PHARMACEUTICAL PREPARATIONS MEDICAL PREPARATIONS

Brand Owner (click to sort) Address Description
DEFLAGYN Selo Medical GmbH Moosham 29 A-5585 Unternberg Austria Pharmaceutical preparations and medical preparations for gynaecological purposes;
DEFLAGYN Selo Medical GmbH Moosham 29 A-5585 Unternberg Austria Pharmaceutical preparations and medical preparations for gynaecological purposes;
NANOTHERM MagForce Nanotechnologies AG Spandauer Damm 130 Berlin D-14050 Germany Pharmaceutical preparations and medical preparations, namely powder, granulates, particles and solid or metallic or magnetic particles for the treatment or prophylaxis of cancer, benign tumors, arthritis, arthrosis, stenoses and restenoses, heart diseases, skin diseases; Pharmaceutical preparations and medical preparations, namely powder, granulates, particles and solid or metallic or magnetic particles for use as medical contrast agents; Pharmaceutical preparations and medical preparations, namely powder, granulates, particles and solid or metallic or magnetic particles for diagnostic and medical purposes, namely, for imaging and detection of cancer, tumors, arthritis, arthrosis, stenosis, restenosis, heart diseases and skin diseases;
TRANSGENE TRANSGENE, S.A. 400 Boulevard Gonthier d'Andernach Parc d'Innovation- CS80166 Illkirch-graffenstaden 67405 France pharmaceutical preparations and medical preparations for use in treatment of cystic fibrosis, cancer, acquired immune deficiency syndrome, multiple sclerosis, autoimmune diseases and hypersensitivities, and hematological conditions;research and scientific studies in the field of chemistry, bacteriology, virology, immunology, molecular biology, genetic engineering, gene therapy and human and veterinary medicine;
TREPULMIX AOP Orphan Pharmaceuticals GmbH Leopold-Ungar-Platz 2 Vienna 1190 Austria Pharmaceutical preparations and medical preparations for the treatment of chronic pulmonary hypertension; pharmaceutical preparations and medical preparations for the treatment of chronic, thromboembolic pulmonary hypertension;
 

Where the owner name is not linked, that owner no longer owns the brand

   
Technical Examples
  1. The invention provides compositions, pharmaceutical preparations and methods for inhibition of cystic fibrosis transmembrane conductance regulator protein (CFTR) that are useful for treating secretory diarrhea. The compositions and pharmaceutical preparations of the invention may comprise one or more thiazolidinone compounds, and may additionally comprise one or more pharmaceutically acceptable carriers, excipients, and/or diluents.